tiprankstipranks
Organogenesis Holdings (ORGO)
NASDAQ:ORGO
US Market

Organogenesis Holdings (ORGO) Income Statement

501 Followers

Organogenesis Holdings Income Statement

Last quarter (Q4 2025), Organogenesis Holdings's total revenue was $225.61M, an increase of 78.13% from the same quarter last year. In Q4, Organogenesis Holdings's net income was $43.70M. See Organogenesis Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 564.17M$ 482.04M$ 433.14M$ 450.89M$ 467.36M
Gross Profit
$ 415.06M$ 366.30M$ 326.66M$ 345.87M$ 353.16M
Operating Expenses
$ 358.68M$ 367.58M$ 314.13M$ 323.57M$ 280.94M
Depreciation and Amortization
$ 26.94M$ 17.03M$ 23.45M$ 18.03M$ 16.68M
EBITDA
$ 83.32M$ 15.76M$ 36.03M$ 40.32M$ 87.00M
Operating Income
$ 56.38M$ -1.28M$ 12.53M$ 22.30M$ 72.22M
Other Income/Expenses
$ -9.41M$ -1.52M$ -2.13M$ -2.02M$ -9.13M
Pretax Income
$ 46.97M$ -2.81M$ 10.39M$ 20.28M$ 63.09M
Net Income
$ 37.03M$ 861.00K$ 4.95M$ 15.53M$ 94.20M
Per Share Metrics
Basic EPS
$ 0.16$ >-0.01$ 0.04$ 0.12$ 0.73
Diluted EPS
$ 0.15$ -0.01$ 0.04$ 0.12$ 0.70
Weighted Average Shares Outstanding
126.74M 131.67M 131.23M 130.07M 128.33M
Weighted Average Shares Outstanding (Diluted)
130.25M 131.67M 132.75M 132.38M 133.66M
Currency in USD

Organogenesis Holdings Earnings and Revenue History